期刊文献+

多种活化因子共刺激对人外周血单个核细胞体外增殖和表型的影响 被引量:11

Co-stimulation of multiple activating factors on proliferation and phenotype of T lymphocytes in peripheral blood in vitro
下载PDF
导出
摘要 目的:观察多种活化因子共刺激后对人外周血淋巴细胞增殖和表型的影响。方法:用淋巴细胞分离液分离人外周血单个核细胞(PBMC),根据加入刺激因子(CD3 mAb、CD28 mAb、IFN-γ、IL-1α、IL-2、IL-15和IL-21)种类和方法不同将实验分为7组。用全自动五分类血液分析仪计数不同细胞因子诱导培养的PBMC增殖力、流式细胞术测定诱导后共刺激细胞表面CD3,CD4,CD8,CD28,CD16、CD56+CD16,CD3+CD8+,CD3+CD4+,CD3+CD56+,CD45RO等分子的变化、乳酸脱氢酶释放法测定诱导后的共刺激细胞对SGC-7901、SW-1990和SW-116细胞株的杀伤活性。结果:在PB-MC培养体系中加入不同的刺激因子其细胞增殖能力有明显的差异,以含刺激因子CD3、CD28、IFN-γ、IL-2、IL-1α、IL-15和IL-21组增殖倍数最高,在培养第10 d时该组的增殖倍数为255.3 6.3,明显高于仅含CD3、IFN-γ和IL-2培养体系组(166.6 5.5)(P<0.05)。在PBMC培养体系中加入不同的刺激因子其部分细胞表面标志有所差异,在培养体系中无IL-15时CD16+CD56+(NK细胞)细胞和CD3+CD56+细胞比例明显高于其他组;CD45RO+的记忆性T细胞以延迟3 d添加IL-15和IL-21组升高最明显。经不同活化因子刺激培养10 d的PBMC对SGC-7901、SW-1990和SW-1116细胞杀伤活性有明显差异,以延迟3 d添加IL-15和IL-21组最高(分别为76.2%、60.3%和70.6%),明显高于仅含CD3、IFN-γ和IL-2培养体系的细胞组(分别为54.9%、44.6%和50.4%)(P<0.05)。培养的细胞对胃腺癌细胞SGC-7901杀伤活性最强。结论:不同刺激因子活化的PBMC其增殖能力、表面标记和杀伤活性有明显差异,在培养体系中增加相应的刺激因子对细胞定向培养有一定价值。 AIM: To observe the costimulation of multiple activating factors effects on the proliferation and phenotype of T lymphocytes in vitro. METHODS: Peripheral blood mononuclear cells (PBMCs) were separated by fractionation on Ficoll-Hypacue gradient. According to adding different cytokines (CD3 mAb, CD28 mAb, IFN-γ, IL-lα, IL-2 and IL-15 ), the experiments were divided into seven groups. Effects of different cytokines on the proliferation of PBMC were counted by automated hematology analyzer five categories. The phenotypes (CD3, CD4, CD8, CD28, CD16, CD56^+ CD16, CD3^+ CD8^+, CD3^+ CD4^+ , CD3^+ CD56^+ , CD45RO) expressing on the surface of costimulatory cells were detected by flow cytometry, and the cytotoxicity of costimulatory cells on SGC-7901, SW-1990 and SW-116 cell lines was examined by lactate dehydrogenase release method. RESULTS: The proliferation has significant difference when adding different cytokines into PBMCs culture system, the highestest proliferation multiples group is the one contains cytokines CD3, CD28, IFN-γ, IL-2, IL-1α, IL-15 and IL-21, which proliferation multiple is 255.3 ± 6.3 at the tenth day of cell culture, obviously higher than the other culture systems which only contains CD3, IFN-γ and IL-2 ( 166.6 +5.5) (P〈0.05). Part of cells' phenotype changed when adding different activating factors. Without IL-15, the proportion of CD16^+ CD56^+ (NK) cells and CD3^+ CD56^+ cells was higher than the other groups; CD45RO^+ memory cells is most evident when delayed adding IL-15 and IL-21 for three days. The cytotoxicity of PBMCs cultured for ten days with different activating factors had significant difference, the highest was the one which delayed adding IL-15and IL-21 for three days (76.2%, 60.3% and ?0.6%, respectively. ), higher than the cell culture groups containing CD3, IFN-γ and IL-2 (54. 9%, 44. 6% and 50. 4%, respectively) (P〈0.05). The cultured cells had the strongest cytotoxicity on SGC-7901 gastric adenocarcinoma cells. CONCLUSION: The PBMCs' proliferation, phenotype and cytotoxicity had significant difference after being activated by different stimulating factors, adding matching stimulating factors into the culture system have great value on celldirected culture.
机构地区 解放军第 解放军第
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2012年第4期367-370,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 南京军区医学科技创新课题(09MA037)
关键词 共刺激 单个核细胞 增殖 T淋巴细胞表型 杀伤活性 costimulate PBMC proliferation T lymphocytes phenotype cytotoxicity
  • 相关文献

参考文献21

  • 1撒亚莲,沈晓梅,史克倩,唐慧,赵仁彬,陆洁,宋建新,严新民.hMSC对异体DC-CIK细胞分泌细胞因子的影响[J].细胞与分子免疫学杂志,2010,26(10):988-991. 被引量:10
  • 2刘季芳,刘枫,祁岩超,杨波,卢敏莹,潘东晓,申鸿卓.IFN-γ逆转免疫编辑后人肺癌A549细胞对CIK杀伤敏感性的研究[J].细胞与分子免疫学杂志,2010,26(4):354-355. 被引量:10
  • 3刘军权 韩慧敏 陈复兴.用乳酸脱氢酶试剂盒检测LAK细胞活性.临床检验杂志,1995,.
  • 4陈复兴 刘军权 许祥裕 等.人CD3单克隆抗体体外诱导T淋巴细胞和肿瘤浸润性淋巴细胞增殖的研究.南京部队医药,1994,5:15-18.
  • 5Thorne SH,Negrin RS,Contag CH,et al.Synergistic an titum or ef-fectsof immune cell-viral biotherapy[J].Science,2006,311(5768):1780-1784.
  • 6Radhakrishnan S,Nguyen LT,Ciric B,et al.B7-DC/PD-L2cross-link ing induces NF-kappa B-dependent protection of dendritic cellsfrom cell death[J].J Immunol,2007,178(3):1426-1432.
  • 7Sharpe AH,Freeman GJ.The B7-CD28 superfamily[J].Nat Immu-nol,2002,2(2):116-126.
  • 8Vasir B,Wu Z,Crawford K,et al.Fusions of dendritic cells withbreast carcinoma stimulate the expansion of regulatory T cells whileconcomitant exposure to IL-12,CpG oligodeoxynucleotides,and anti-CD3/CD28 promotes the expansion of activated tumor reactive cells[J].J Immunol,2008,181(1):808-821.
  • 9Riha P,Rudd CE.CD28 co-signaling in the adaptive immuneresponse[J].Self Nonself,2010,1(3):231-240.
  • 10Montagmoli C,Bacci A,Boxxa S,et al.B7/CD28-dependent CD4+CD25+regulatory T cell are essential components of the mimory-protective immunity to candida albicans[J].J Immunol,2002,169(11):6298-6308.

二级参考文献25

  • 1丁军颖,王润田.人MICA基因多态性和表达特性与肿瘤的关系[J].现代免疫学,2007,27(2):165-168. 被引量:10
  • 2栾希英,张光波,胡玉敏,於葛华,王明元,段巧艳,段祥,张学光.人骨髓MSC对PHA活化T细胞周期以及表型和细胞因子分泌的影响[J].细胞与分子免疫学杂志,2007,23(5):402-405. 被引量:16
  • 3Dunn GP, Bruce AT, Iked AH, et al. Cancer immunoediting: from immunosurveillance to tumor escape [ J ]. Nat Immunol, 2002, 3 (11) : 991 -998.
  • 4Kacani L, Wurm M, Schennach H, et al. Immunosuppressive effects of soluble factors serected by head and neck squamous cell carcinoma on dendritic cells and T lymphocytes[ J]. Oral Oncol, 2003, 39(7) : 672 - 679.
  • 5Busche A, Goldmann T, Naumannu, et al. Natural killer cell-mediated rejection of experimental human lung cancer by genetic overexpression of major histocompatibility complex class I chain-related gene A [J]. Hum Gene Ther, 2006, 17(2) : 135 -146.
  • 6Dunn GP, Koebel CM, Scheriber RD. Interferon-gamma and cancer immunoediting[ J ]. Immunol Res, 2005, 32 ( 1 - 3 ) : 231 - 245.
  • 7Reu FJ, Bae SI, Cherkassky L, et al. Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation[ J]. J Clin Oncol, 2006, 24(23) : 3771 -3779.
  • 8Schmidt-Wolf IG, Finke S, Trojaneck B, et al. Phase I clinical study applying autologous immunological effec/or cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma[ J ]. Br J Cancer, 1999, 81 (6) : 1009 - 1016.
  • 9Banchereau J, Steinman RM. Dendritic cells and the control of immunity[J]. Nature, 1998, 392(6673): 245-252.
  • 10Marten A, Ziske C, Schottker B, et al. Interactions between dendritic cells and cytokine-induced killer cells lead to an activation of both populations[J]. J Immunother, 2001, 24(6): 502-510.

共引文献26

同被引文献145

引证文献11

二级引证文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部